Supplemental Figure 1-2 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
Year: 2023
Type: supplementary-materials
Abstract: Supplemental Figure 1-2. Supplemental Figure 1: Pharmacology of POL5551; Supplemental Figure 2: Correlation of CXCR4 expression in primary tumor with survival in patients
Authors: Jingyu Xiang, Michelle A. Hurchla, Francesca Fontana, Xinming Su, Sarah R. Amend, Alison K. Esser, Garry J. Douglas, Chidananda Mudalagiriyappa, Kathryn E. Luker, Timothy Pluard, Foluso O. Ademuyiwa, Barbara Romagnoli, Gérald Tuffin, Eric Chevalier, Gary D. Luker, Michael Bauer, Johann Zimmermann, Rebecca L. Aft, Klaus Dembowsky, Katherine N. Weilbaecher
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362623503
